Pasar al contenido principal

NUEVAS APLICACIONES DEL SISTEMA CRISPR-CAS IN VIVO PARA IDENTIFICAR FACTORES INVOLUCRADOS EN EL DESARROLLO TEMPRANO DE VERTEBRADOS

PGC2018-097260-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD PABLO DE OLAVIDE, DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RIO. Repositorio Institucional Olavide
Publicación Artículo científico (JournalArticle)

Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes

  • Vicencio, Jeremy
  • Sánchez-Bolaños, Carlos
  • Moreno-Sánchez, Ismael|||0000-0001-5606-4028
  • Brena, David
  • Vejnar, Charles E.
  • Kuthar, Dmytro
  • Ruiz-López, Miguel
  • Cots-Ponjoan, Mariona
  • Rubio Valle, Alejandro|||0000-0002-6736-6141
  • Rodrigo Melero, Natalia
  • Crespo Cuadrado, Jesús|||0000-0002-3741-7729
  • Carolis, Carlos
  • Pérez-Pulido, Antonio J.|||0000-0003-3343-2822
  • Giraldez, Antonio J.
  • Kleinstiver, Benjamin P.
  • Cerón, Julián
  • Moreno Mateos, Miguel A.|||0000-0001-5723-0569
The requirement for Cas nucleases to recognize a specific PAM is a major restriction for genome editing. SpCas9 variants SpG and SpRY, recognizing NGN and NRN PAMs, respectively, have contributed to increase the number of editable genomic sites in cell cultures and plants. However, their use has not been demonstrated in animals. Here we study the nuclease activity of SpG and SpRY by targeting 40 sites in zebrafish and C. elegans. Delivered as mRNA-gRNA or ribonucleoprotein (RNP) complexes, SpG and SpRY were able to induce mutations in vivo, albeit at a lower rate than SpCas9 in equivalent formulations. This lower activity was overcome by optimizing mRNA-gRNA or RNP concentration, leading to mutagenesis at regions inaccessible to SpCas9. We also found that the CRISPRscan algorithm could help to predict SpG and SpRY targets with high activity in vivo. Finally, we applied SpG and SpRY to generate knock-ins by homology-directed repair. Altogether, our results expand the CRISPR-Cas targeting genomic landscape in animals.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos

  • Kushawah, Gopal
  • Abugattas-Nuñez del Prado, Joaquin A.
  • Martínez-Morales, Juan Ramón
  • DeVore, Michelle L.
  • Hassan, Huzaifa
  • Moreno-Sánchez, Ismael
  • Tomás-Gallardo, Laura
  • Díaz Moscoso, Alejandro
  • Monges, Dahiana E.
  • Guelfo, Javier R.
  • Theune, William C.
  • Brannan, Emry O.
  • Wang, Wei
  • Corbin, Timothy J.
  • Moran, Andrea M.
  • Sánchez Alvarado, Alejandro
  • Málaga-Trillo, Edward
  • Takacs, Carter M.
  • Bazzini, Ariel A.
  • Moreno-Mateos, Miguel A.
Early embryonic development is driven exclusively by maternal gene products deposited into the oocyte. Although critical in establishing early developmental programs, maternal gene functions have remained elusive due to a paucity of techniques for their systematic disruption and assessment. CRISPR-Cas13 systems have recently been employed to degrade RNA in yeast, plants, and mammalian cell lines. However, no systematic study of the potential of Cas13 has been carried out in an animal system. Here, we show that CRISPR-RfxCas13d (CasRx) is an effective and precise system to deplete specific mRNA transcripts in zebrafish embryos. We demonstrate that zygotically expressed and maternally provided transcripts are efficiently targeted, resulting in a 76% average decrease in transcript levels and recapitulation of well-known embryonic phenotypes. Moreover, we show that this system can be used in medaka, killifish, and mouse embryos. Altogether, our results demonstrate that CRISPR-RfxCas13d is an efficient knockdown platform to interrogate gene function in animal embryos., This work was supported by Ramon y Cajal program (RyC-2017-23041) and grants PGC2018-097260-B-I00 and MDM-2016-0687 from Spanish Ministerio de Ciencia, Innovación y Universidades and the Springboard program from CABD (M.A.M.-M.) and the Stowers Institute for Medical Research (A.A.B.). M.A.M.-M. was the recipient of the Genome Engineer Innovation 2019 Grant from Synthego. A.A.B. was awarded with Pew Innovation Fund. J.R.M.-M. is supported by BFU2017-86339-P and MDM-2016-0687 grants (Spanish Ministerio de Ciencia, Innovación y Universidades). E.M.-T. and J.A.-N.d.P. are supported by INNOVATE PERÚ grant 168-PNICP-PIAP-2015 and FONDECYT travel grant 043-2019., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optimized CRISPR-RfxCas13d system for RNA targeting in zebrafish embryos

  • Hernández-Huertas, Luis
  • Kushawah, Gopal
  • Diaz-Moscoso, Alejandro
  • Tomás-Gallardo, Laura
  • Moreno-Sánchez, Ismael
  • Silva Pescador, Gabriel da
  • Bazzini, Ariel A.
  • Moreno-Mateos, Miguel A.
CRISPR-Cas systems have been used to induce DNA mutagenesis for gene function discovery. However, the development of tools to eliminate RNAs provides complementary and unique approaches to disrupt gene expression. Here, we present a workflow to perform specific, efficient, and cost-effective mRNA knockdown in zebrafish embryos using our in vivo optimized CRISPR-RfxCas13d (CasRx) system. Although the described protocol focuses on mRNA knockdown in zebrafish embryos, it can also be applied to other vertebrates., This work was supported by Ramon y Cajal (RyC-2017-23041), PGC2018-097260-B-I00 grant and MDM-2016-0687 program (Spanish Ministerio de Ciencia, Innovación y Universidades, and European Union), Universidad Pablo de Olavide (UPO) Research and the Springboard programs from UPO and CABD, respectively (M.A.M.-M.). This study was supported by the Stowers Institute for Medical Research. A.A.B. was awarded a Pew Innovation Fund and the US National Institutes of Health (R01 GM136849). This work was performed as part of the research for the obtainment of a G.dS.P degree., Graduate School of the Stowers Institute for Medical Research. The CABD is an institution funded by Pablo de Olavide University, Consejo Superior de Investigaciones Científicas (CSIC), and Junta de Andalucía. L.H.-H. is a recipient of a predoctoral fellowship from Ministerio de Ciencia.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes

  • Vicencio, Jeremy
  • Sánchez-Bolaños, Carlos
  • Moreno-Sánchez, Ismael
  • Brena, David
  • Vejnar, Charles E.
  • Kukhtar, Dmytro
  • Ruiz-López, Miguel
  • Cots-Ponjoan, Mariona
  • Rubio, Alejandro
  • Rodrigo Melero, Natalia
  • Crespo-Cuadrado, Jesús
  • Carolis, Carlo
  • Pérez-Pulido, Antonio J.
  • Giraldez, Antonio J.
  • Kleinstiver, Benjamin P.
  • Cerón, Julián
  • Moreno-Mateos, Miguel A.
The requirement for Cas nucleases to recognize a specific PAM is a major restriction for genome editing. SpCas9 variants SpG and SpRY, recognizing NGN and NRN PAMs, respectively, have contributed to increase the number of editable genomic sites in cell cultures and plants. However, their use has not been demonstrated in animals. Here we study the nuclease activity of SpG and SpRY by targeting 40 sites in zebrafish and C. elegans. Delivered as mRNA-gRNA or ribonucleoprotein (RNP) complexes, SpG and SpRY were able to induce mutations in vivo, albeit at a lower rate than SpCas9 in equivalent formulations. This lower activity was overcome by optimizing mRNA-gRNA or RNP concentration, leading to mutagenesis at regions inaccessible to SpCas9. We also found that the CRISPRscan algorithm could help to predict SpG and SpRY targets with high activity in vivo. Finally, we applied SpG and SpRY to generate knock-ins by homology-directed repair. Altogether, our results expand the CRISPR-Cas targeting genomic landscape in animals., Ceron laboratory thanks the CERCA Program (Generalitat de Catalunya) for their institutional support, and Nicholas Stroustrup and Alberto Villanueva for sharing reagents and equipment, and Marta Artal and Antonio Miranda for allowing to share the information on the efficiency of the trx-1 and usp-48 endogenous reporters generation. We thank Erik Jorgensen for sharing the EG9615 strain. We thank Jordan Ward for hosting J.C. at the UCSC where cki-1 tagging was performed. This study at Cerón Lab has been funded by Ministerio de Ciencia, Innovación y Universidades, which is part of Agencia Estatal de Investigación (AEI), through the Retos grant, number PID2020-114986RB-100. This work was also supported by Ramon y Cajal (RyC-2017-23041) and MDM-2016-0687 programs (Spanish Ministerio de Ciencia, Innovación y Universidades), Universidad Pablo de Olavide (UPO) Research and the Springboard programs from UPO and CABD, respectively and has been co-funded by the Fondo Europeo de Desarrollo Regional (FEDER) and Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía, within the operative program FEDER Andalucía 2014-2020 (01 - Refuerzo de la investigación, el desarrollo tecnológico y la innovación, grant P20_00866) (M.A.M.-M.). The Moreno-Mateos lab is supported by PGC2018-097260-B-I00 grant from Spanish Ministerio de Ciencia, Innovación y Universidades and European Union. The CABD is an institution funded by Pablo de Olavide University, Consejo Superior de Investigaciones Científicas (CSIC), and Junta de Andalucía. C.S.-B. was a recipient of the Ayudas Puente Predoctorales (Universidad Pablo de Olavide, V Plan Propio de Investigación y transferencia). J.V. had an INPhINIT PhD fellowship from “la Caixa” Foundation (LCF/BQ/IN17/11620065) co-funded by Marie Skłodowska-Curie grant agreement no. 713673. D.B. is a predoctoral fellow of the CONACYT “Becas al Extranjero” Program of Mexico. D.K. has an FI AGAUR fellowship (2018FI_B1_00511) from Generalitat de Catalunya. A.J.G. and B.P.K. acknowledge support from National Institutes of Health (NIH) R00 CA218870 and NIH P01 HL142494 (B.P.K.) and 5R35GM122580-05 (A.J.G.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CRISPR-RfxCas13d screening uncovers Bckdk as a post-translational regulator of maternal-to-zygotic transition in teleosts

  • Hernández-Huertas, Luis
  • Moreno-Sánchez, Ismael
  • Crespo-Cuadrado, Jesús
  • Vargas-Baco, Ana
  • Pescador, Gabriel da Silva
  • Zhang, Ying
  • Wen, Zhihui
  • Florens, Laurence
  • Santos-Pereira, José M.
  • Bazzini, Ariel A.
  • Moreno-Mateos, Miguel A.
[Data availability] RNA-seq, ATAC-seq, CUT&RUN, and SLAM-seq data have been deposited in GEO under accession code GSE268294 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268294). Proteomics, phospho-proteomics, and isoleucine-leucine data have been deposited at MassIVE MSV000094733 Valine quantification data have been deposited at MassIVE MSV000094867. The source data of this paper are collected in the following database record: biostudies:S-SCDT-10_1038-S44318-025-00617-8., The maternal-to-zygotic transition (MZT) is a reprograming process encompassing zygotic genome activation (ZGA) and the clearance of maternally-provided mRNAs. While some factors regulating MZT have been identified, there are thousands of maternal RNAs whose function has not been ascribed yet. Here, we have performed a proof-of-principle CRISPR-RfxCas13d maternal screen, in which we targeted mRNAs encoding kinases and phosphatases or proteins regulating them in zebrafish. This screen identified branched-chain ketoacid dehydrogenase kinase, Bckdk, as a novel post-translational regulator of MZT. Bckdk mRNA knockdown caused epiboly defects, ZGA deregulation, H3K27ac reduction and a partial impairment of miR-430 processing. Phospho-proteomic analysis revealed that Phf10/Baf45a, a chromatin remodeling factor, is less phosphorylated upon Bckdk depletion. Further, phf10 mRNA knockdown also altered ZGA, and expression of a phospho-mimetic mutant of Phf10 rescued the developmental defects observed after bckdk mRNA depletion, as well as restored H3K27ac levels. Altogether, our results demonstrate the competence of CRISPR-RfxCas13d screenings to uncover new regulators of early vertebrate development and shed light on the post-translational control of MZT mediated by protein phosphorylation., We thank all members of the Moreno-Mateos and the Bazzini laboratories for their intellectual and technical support. This work was supported by Ramon y Cajal (RyC-2017-23041), PGC2018-097260-B-I00, PID2021-127535NB-I00, MDM-2016-0687, and CEX2020-001088-M grants funded by MICIU/AEI/10.13039/501100011033 by “ERDF A way of making Europe”, “ERDF/EU” and by ESF Investing in your future from Ministerio de Ciencia, Innovación y Universidades and European Union (MAM-M). MAM-M was the recipient of the Genome Engineer Innovation 2019 Grant from Synthego. The Moreno-Mateos lab has been also co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU (PRTR-C17.I1) and the Regional Ministry of University, Research and Innovation of the Autonomous Community of Andalusia within the framework of the Biotechnology Plan applied to Health, grant CNS2022-135564 funded by MICIU/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR, the European Regional Development Fund (FEDER 80% of the total funding) by the Ministry of Economy, Knowledge, Business and University, of the Government of Andalusia, within the framework of the FEDER Andalusia 2014-2020 operational program within the objective “Promotion and generation of frontier knowledge and knowledge oriented to the challenges of society, development of emerging technologies (grant UPO-1380590)” and by the Fondo Europeo de Desarrollo Regional (FEDER) and Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía, within the operative program FEDER Andalucía 2014-2020 (01—Refuerzo de la investigación, el desarrollo tecnológico y la innovación, grant P20_00866). The CABD is an institution funded by Pablo de Olavide University, Consejo Superior de Investigaciones Científicas (CSIC), and Junta de Andalucía. LH-H was a recipient of ayudas para contratos predoctorales para la formación de doctores contemplada en el Subprograma Estatal de Formación del Programa Estatal de Promoción del Talento y su Empleabilidad en I + D + i, en el marco del Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (Ministerio de Ciencia e Innovación). JC-C is supported by the Junta de Andalucía Predoctoral Grant (PREDOC_01569), respectively. IM-S was a recipient of the Margarita Salas Postdoctoral contract funded by “NextGenerationEU”, Plan de Recuperación, Transformación y Resilencia and Ministerio de Universidades (recualificación del sistema universitario español 2021-2023, Pablo de Olavide University Call). JMS-P was funded by an Emergia grant from Junta de Andalucía (EMC21_00188). This study was supported by the Stowers Institute for Medical Research. AAB was awarded a US National Institutes of Health grant (NIH-R01 GM136849 and NIH R21OD034161). This work was performed as part of thesis research for the GdSP, Graduate School of the Stowers Institute for Medical Research grants. We thank our colleagues Juan Ramon Martínez-Morales, Barbara Pernaute and Thomas Spruce (CABD, Seville, Spain), and Jose Carlos Reyes (CABIMER, Seville, Spain) for the critical reading of the manuscript. We also thanks Rhonda Egidy and Anoja Perera from Sequencing and Discovery Genomics facility at (Kansas, MO, USA), Danielson Baia Amaral (Stowers Institute) for technical support in performing injections, embryo collection, photography, and qPCR for Valine quantification experiments, applying Slamdunk pipeline and providing suggestions on the manuscript draft, Juan J. Tena, Thirsa Brethouwer and Cielo Centola (CABD, Seville, Spain) for H3K27ac antibody, and helping with CUT&RUN experiment and synopsis image, respectively., With funding form the Spanish government through the “María de Maeztu Unit of Excellence” accreditation (CEX2020-001088-M)., Peer reviewed